Drug Database
Back to search

Belgium· BE-AMP-SAM177694-00

Campral 333 mg

A acamprosate product containing acamprosate, registered in Belgium by Merck. The same ATC class is registered in 14 of our 19 countries.

ATC N07BB03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedCampral 333 mgATCN07BB03REGISTER NO.BE-AMP-SAM177694-00PACKS LISTED3CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acamprosateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Acamprosate is registered in 14 of 19 countries.

Countries holding a registration under ATC N07BB03 (acamprosate), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search acamprosate products by name

Acamprosate · ATC N07BB03

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acamprosate costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $1.14 in France to $3.37 in Switzerland — a ×3.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Acamprosate · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.37
  • IT Italy$2.75
  • FR France$1.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Acamprosate
Manufacturer
Merck
Country
Belgium (BE)
ATC code
N07BB03
ATC class
Acamprosate
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 3

1 priced
  • be_apb
    1741487
    EUR 42.56
  • be_apb
    1284280
  • be_apb
    0763029

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

19 interactions on record for acamprosate.

Graded by severity as the source publishes them — 19 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check acamprosate against other medicinesHow interaction checks work

Acamprosate · interactions on record

19 records

  • 19 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Acamprosate in 13 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All acamprosate products

    Authorised across Europe · EMA

    The same active substance is authorised in 15 EEA countries. Names it is sold under:

    • Austria · Campral
    • Czechia · Campral
    • Germany · Campral
    • Spain · Campral
    • France · Acamprosate Biogaran, Acamprosate Viatris
    • United Kingdom (Northern Ireland) · Acamprosate Generics [uk] Ltd, Acamprosate Strandhaven Somex Pharma
    • Ireland · Campral Ec
    • Italy · Campral
    • Luxembourg · Campral
    • Netherlands · Campral
    • Norway · Campral
    • Poland · Campral
    • Portugal · Campral
    • Sweden · Akamprosat Viatris, Campral
    • Slovakia · Acamprosat Viatris, Campral

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/54c9e382-a026-4bdf-8d75-412529c3d3ea
GET /v1/drugs/54c9e382-a026-4bdf-8d75-412529c3d3ea?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Gastro-resistant tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Campral 333 mg",
  "name_fr": "Campral 333 mg",
  "name_nl": "Campral 333 mg",
  "amp_code": "SAM177694-00",
  "strengths": [
    "333.0000",
    "4.2000",
    "10.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Acamprosate",
    "Propylene Glycol",
    "Sodium Starch Glycolate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Acamprosate",
  "authorisation_numbers": [
    "BE177694"
  ]
}
    API referenceMCP serverPlans

    See everything about acamprosate.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console